Fieldview Capital Management, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2040221
NILES, MI
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$298,309
-$4,792,945 QoQ
Shares Held
595
-94.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,053
of 2,606 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fieldview Capital Management, LLC holds $4,957,931 across 8 Diagnostics & Research names. TMO ranks #8 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
13,858 | $2,079,115 | |
| 2 | NTRA |
Natera, Inc.
|
1,756 | $476,666 | |
| 3 | WAT |
Waters Corp /De/
|
1,224 | $459,048 | |
| 4 | DHR |
Danaher Corp /De/
|
2,315 | $440,961 | |
| 5 | SHC |
Sotera Health Co
|
24,465 | $434,253 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,407 | $393,960 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,944 | $375,619 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
This page
|
595 | $298,309 |
All Filings in TMO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $298,309 | 595 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $5,091,254 | 10,497 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $3,233,902 | 6,499 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $316,820 | 609 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||